ocular use

DRUG2 trials

Sponsors

Oculis Operations S.a.r.l.

Conditions

Diabetic Macular Edema (DME)

Phase 2

A Phase 2/3 Double-masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

CompletedCTIS2023-507208-30-00

Oculis Operations S.a.r.l.Diabetic Macular Edema (DME)

Start: 2022-09-20End: 2024-07-29Target: 49Updated: 2024-04-12

Phase 3

A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

CompletedCTIS2023-507207-66-00

Oculis Operations S.a.r.l.Diabetic Macular Edema (DME)

End: 2024-07-29Target: 133Updated: 2024-05-24